New hope for kids with hepatitis b: drug trial shows promise
NCT ID NCT01651403
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested an antiviral drug called tenofovir in children aged 2 to 12 with chronic hepatitis B. The goal was to see if the drug could lower the amount of virus in their blood compared to a placebo. The trial involved 90 children and measured safety and effectiveness over 48 weeks.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC HEPATITIS B are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Asan Medical Center
Seoul, 05505, South Korea
-
Children's Hospital Colorado
Aurora, Colorado, 80045, United States
-
Cincinnati Children's Hospital Medical Center
Cincinnati, Ohio, 45229, United States
-
Colors Children Hospital
Nagpur, Maharashtra, 440012, India
-
Fundeni Clinical Institute - Constantinesco
Bucharest, 022328, Romania
-
Grigore Alexandrescu Emergency Clinical Hospital for Children
Bucharest, 011743, Romania
-
Kyungpook National University
Daegu, 41944, South Korea
-
M.V. Hospital and Research Centre 314/30 Mirza Mandi Chowk
Lucknow, Uttar Pradesh, 226003, India
-
Medanta -The Medicity
Gurgaon, Haryana, 122 001, India
-
National Taiwan University Hospital
Taipei, 100, Taiwan
-
Nirmal Hospital Private Limited
Surat, Gujarat, 395 002, India
-
Phoenix Children's Hospital
Phoenix, Arizona, 85016, United States
-
Pusan National University Yangsan Hospital
Yangsan, Gyeongsangnam-do, 50612, South Korea
-
SMS Medical College and Hospital
Jaipur, Rajasthan, 302004, India
-
Samsung Medical Center
Seoul, 06351, South Korea
-
Severance Children's Hospital
Seoul, 120-752, South Korea
-
St. John Hospital & Medical Center
Bangalore, 560034, India
-
Taipei Veterans General Hospital
Taipei, 11217, Taiwan
-
Texas Children's Hospital
Houston, Texas, 77030, United States
-
University of California, San Francisco
San Francisco, California, 94143, United States
-
Victor Babes Clinical Hospital of Infectious Diseases and Pneumophtisology
Craiova, 200515, Romania
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a simple scan and blood test outsmart liver cancer?
- Can a new injection tame chronic hepatitis b?
- Double liver trouble: does having both hepatitis b and fatty liver speed up disease?
- A second punch against hepatitis b: interferon after RNA drugs may clear the virus
- Could common hepatitis b drugs damage kidneys? a study digs into the data
- Can fatty liver and hepatitis b together harm kidneys? a study digs into the data